|
|
Article: Agreement signed between pharma companies for allergy, hypertension medications.(Grupo Uriach)
- Article from:
- World Disease Weekly
- Article date:
- October 12, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 OCT 12 - (NewsRx.com & NewsRx.net) -- Recordati announced that it has signed a series of license agreements with the Spanish pharmaceutical company Grupo Uriach for the marketing and sale in Italy and in France of rupatadine, an antihistamine drug indicated for the treatment of allergies.
The agreements also include license options for Germany, Poland and the United Kingdom.
These agreements follow the license obtained last year from Uriach for the sale of rupatadine in Spain. This product was then launched by Recordati Espana as Alergoliber at the beginning of this year.
Rupatadine, researched and developed by Uriach, is a latest ...